Abstract
Purpose
To characterize the frozen oocyte disposition preferences of patients undergoing medical and planned fertility preservation.
Methods
All oocyte cryopreservation (OC) patients were identified between 2015 and 2018. Demographic information and fertility preservation (FP) indication (medical or planned) were identified for each patient. Oocyte disposition options included disposal, donation to research, or donation to a specified third party, which was decided at the time of initial consent and made available in the electronic medical record. The primary outcome was the disposition selection. Secondary outcomes included differences in demographic variables and disposition selections between medical and planned FP patients using chi-squared analysis.
Results
A total of 336 OC patients with a documented oocyte disposition preference were identified in the study timeframe. Patients were on average 34.5 years old (SD = 5.1) and were predominantly White (70.2%), nulliparous (83.0%), with a BMI of 24.7 (SD = 5.4). A total of 101 patients underwent OC for medical FP and 235 for planned FP. In both groups, the most commonly selected disposition option was donation to research (50% planned, 52% medical), followed by donation to a specified third party (30% planned, 30% medical), and finally disposal of oocytes (20% planned, 18% medical). There were no significant differences in disposition selection between each group. When comparing patient variables between groups, medical FP patients were more likely to be under the age of 35 and were less likely to be nulliparous (p < .001).
Conclusion
This study shows that oocyte disposition choices are similar in patients undergoing OC for medical and planned indications. As donation to research was the most commonly selected option in both groups, it is time to start thinking of streamlining ways to utilize this potential research material in the future.
Similar content being viewed by others
References
Ethics Committee of the American Society for Reproductive Medicine. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion. Fertil Steril. 2018;110:1022–8. https://doi.org/10.1016/j.fertnstert.2018.08.027.
Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril. 2018;110:380–6. https://doi.org/10.1016/j.fertnstert.2018.05.034.
Society for Assisted Reproductive Technology (SART) national summary report. Preliminary national summary report for 2014. Available at: https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?reportingYear=2014. Accessed 23rd January 2022.
Society for Assisted Reproductive Technology (SART) national summary report. Preliminary national summary report for 2018. Available at: https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?reportingYear=2019. Accessed 23rd January 2022.
Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000–2014. NCHS Data Brief. 2016:1–8.
Lewis EI, Missmer SA, Farland LV, Ginsburg ES. Public support in the United States for elective oocyte cryopreservation. Fertil Steril. 2016;106:1183–9. https://doi.org/10.1016/j.fertnstert.2015.10.026.
Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. Births: final data for 2018. Natl Vital Stat Rep. 2019;68(13):1–47.
Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2016 assisted reproductive technology national summary report. Atlanta: US Dept of Health and Human Services; 2018.
van de Wiel L. The speculative turn in IVF: egg freezing and the financialization of fertility. New Genet Soc. 2020;39(3):306–26. https://doi.org/10.1080/14636778.2019.1709430.
Mills M, Rindfuss RR, McDonald P, Te Velde E. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update. 2011;17:848–60. https://doi.org/10.1093/humupd/dmr026.
Hodes-Wertz B, Druckenmiller S, Smith M, Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility? Fertil Steril. 2013;100:1343–9. https://doi.org/10.1016/j.fertnstert.2013.07.201.
Ikhena-Abel DE, Confino R, Shah NJ, Lawson AK, Klock SC, Robins JC, et al. Is employer coverage of elective egg freezing coercive?: a survey of medical students’ knowledge, intentions, and attitudes towards elective egg freezing and employer coverage. J Assist Reprod Genet. 2017;34:1035–41. https://doi.org/10.1007/s10815-017-0956-9.
Moravek MB, Confino R, Smith KN, Kazer RR, Klock SC, Lawson AK, et al. Long-term outcomes in cancer patients who did or did not pursue fertility preservation. Fertil Steril. 2018;109:349–55. https://doi.org/10.1016/j.fertnstert.2017.10.029.
Akel RA, Guo XM, Moravek MB, Confino R, Smith KN, Lawson AK, et al. Ovarian stimulation is safe and effective for patients with gynecologic cancer. J Adolesc Young Adult Oncol. 2020;9:367–74. https://doi.org/10.1089/jayao.2019.0124.
Friedrich A. A cold yield. Cryopreserved oocytes of “social freezing” customers as potential option values for biomedical research. New Genet Soc. 2020;39(3):327–51. https://doi.org/10.1080/14636778.2020.1755637.
Wafi A, Nekkebroeck J, Blockeel C, De Munck N, Tournaye H, De Vos M. A follow-up survey on the reproductive intentions and experiences of women undergoing planned oocyte cryopreservation. Reprod Biomed Online. 2020;40:207–14. https://doi.org/10.1016/j.rbmo.2019.11.010.
Sheffer-Mimouni G, Mashiach S, Dor J, Levran D, Seidman DS. Factors influencing the obstetric and perinatal outcome after oocyte donation. Hum Reprod. 2002;17:2636–40. https://doi.org/10.1093/humrep/17.10.2636.
Sauer MV. Reproduction at an advanced maternal age and maternal health. Fertil Steril. 2015;103:1136–43. https://doi.org/10.1016/j.fertnstert.2015.03.004.
Hounshell CV, Chetkowski RJ. Donation of frozen embryos after in vitro fertilization is uncommon. Fertil Steril. 1996;66:837–8.
Cattoli M, Borini A, Bonu MA. Fate of stored embryos: our 10 years experience. Eur J Obstet Gynecol Reprod Biol. 2004;115 Suppl 1:S16–8. https://doi.org/10.1016/j.ejogrb.2004.01.008.
de Lacey S. Parent identity and ‘virtual’ children: why patients discard rather than donate unused embryos. Hum Reprod. 2005;20:1661–9. https://doi.org/10.1093/humrep/deh831.
Alexander VM, Riley JK, Jungheim ES. Recent trends in embryo disposition choices made by patients following in vitro fertilization. J Assist Reprod Genet. 2020;37(11):2797–804. https://doi.org/10.1007/s10815-020-01927-y.
Ethics Committee of the American Society for Reproductive Medicine. Disposition of unclaimed embryos: an Ethics Committee opinion. Fertil Steril. 2021;116(1):48–53. https://doi.org/10.1016/j.fertnstert.2021.02.020.
Hammarberg K, Tinney L. Deciding the fate of supernumerary frozen embryos: a survey of couples’ decisions and the factors influencing their choice. Fertil Steril. 2006;86(1):86–91. https://doi.org/10.1016/j.fertnstert.2005.11.071.
Caughey LE, Lensen S, White KM, Peate M. Disposition intentions of elective egg freezers toward their surplus frozen oocytes: a systematic review and meta-analysis. Fertil Steril. 2021;116(6):1601–19. https://doi.org/10.1016/j.fertnstert.2021.07.1195.
Leung AQ, Baker K, Vaughan D, et al. Clinical outcomes and utilization from over a decade of planned oocyte cryopreservation. Reprod Biomed Online. 2021;43(4):671–9. https://doi.org/10.1016/j.rbmo.2021.06.024.
Blakemore JK, Grifo JA, DeVore SM, Hodes-Wertz B, Berkeley AS. Planned oocyte cryopreservation-10-15-year follow-up: return rates and cycle outcomes. Fertil Steril. 2021;115(6):1511–20. https://doi.org/10.1016/j.fertnstert.2021.01.011.
Rinehart LA. Storage, transport, and disposition of gametes and embryos: legal issues and practical considerations. Fertil Steril. 2021;115(2):274–81. https://doi.org/10.1016/j.fertnstert.2020.11.025.
Lyerly AD, Steinhauser K, Voils C, Namey E, Alexander C, Bankowski B, et al. Fertility patients’ views about frozen embryo disposition: results of a multi-institutional U.S. survey. Fertil Steril. 2010;93(2):499–509. https://doi.org/10.1016/j.fertnstert.2008.10.015.
Mayor S. HFEA allows women to donate eggs for research. BMJ. 2007;334(7591):445. https://doi.org/10.1136/bmj.39139.478345.DB.
Inhorn MC, Birenbaum-Carmeli D, Westphal LM, et al. Patient-centered elective egg freezing: a binational qualitative study of best practices for women’s quality of care. J Assist Reprod Genet. 2019;36(6):1081–90. https://doi.org/10.1007/s10815-019-01481-2.
Söderström-Anttila V. Follow-up study of Finnish volunteer oocyte donors concerning their attitudes to oocyte donation. Hum Reprod. 1995;10(11):3073–6. https://doi.org/10.1093/oxfordjournals.humrep.a135852.
de Lacey S. Decisions for the fate of frozen embryos: fresh insights into patients’ thinking and their rationales for donating or discarding embryos. Hum Reprod. 2007;22(6):1751–8. https://doi.org/10.1093/humrep/dem056.
Kirkman M. Egg and embryo donation and the meaning of motherhood. Women Health. 2003;38(2):1–18. https://doi.org/10.1300/J013v38n02_01.
Klock SC, Sheinin S, Kazer RR. The disposition of unused frozen embryos. N Engl J Med. 2001;345(1):69–70. https://doi.org/10.1056/NEJM200107053450118.
Newton CR, Fisher J, Feyles V, Tekpetey F, Hughes L, Isacsson D. Changes in patient preferences in the disposal of cryopreserved embryos. Hum Reprod. 2007;22(12):3124–8. https://doi.org/10.1093/humrep/dem287.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
Institutional Review Board (IRB) approval was obtained.
Consent to participate
Waiver of informed consent was approved by IRB given retrospective nature of study.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hutchinson, A.P., Hosakoppal, S., Trotter, K.A. et al. Disposition preferences in oocyte preservation patients. J Assist Reprod Genet 39, 1619–1624 (2022). https://doi.org/10.1007/s10815-022-02518-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-022-02518-9